BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
TRV
The Travelers Companies, Inc.
TRV has a slight edge over BAC overall, supported by stronger valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
TRV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
TRV's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like TRV.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
TRV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $407 | +0.9% |
| Current | 11x | $403 | — |
| Fair | 13x | $505 | +25% |
| Forward | 13x | $403 | — |
| Expensive | 16x | $603 | +50% |
Historical ranges are pointers, not guarantees.
TRV has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over TRV on the outlook, with more favorable valuation and revenue expectations.
TRV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect TRV's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
TRV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.64 | -19% |
| Q3 2026 | $38.04 | +50% |
| Q2 2026 | $37.24 | +65% |
| Q1 2026 | $33.51 | +82% |
| Q4 2025 | $27.43 | +28% |
| Q3 2025 | $25.43 | +30% |
| Q2 2025 | $22.61 | +43% |
| Q1 2025 | $18.37 | +36% |
| Q4 2024 | $21.47 | +68% |
TRV has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over TRV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over TRV on profitability, with a higher operating margin.
TRV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.4B | -0.5% |
| Q2 2026 | $12.2B | +0.3% |
| Q1 2026 | $11.9B | +1% |
| Q4 2025 | $12.4B | +3.5% |
| Q3 2025 | $12.5B | +4.8% |
| Q2 2025 | $12.1B | +7.4% |
| Q1 2025 | $11.8B | +5.2% |
| Q4 2024 | $12B | +9.9% |
TRV's revenue grew through 2024 and has held roughly level since: $12.4B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | +0.3 points |
| Q2 2026 | 23% | +7.3 points |
| Q1 2026 | 18% | +14 points |
| Q4 2025 | 25% | +3.4 points |
| Q3 2025 | 19% | +5.7 points |
| Q2 2025 | 16% | +9.7 points |
| Q1 2025 | 4% | -8.2 points |
| Q4 2024 | 22% | +3.1 points |
TRV's operating margin was 19% last quarter, about level with the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
TRV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.9B | -8.3% |
| Q2 2026 | $1.9B | -18% |
| Q1 2026 | $2.2B | +62% |
| Q4 2025 | $2.7B | +30% |
| Q3 2025 | $4.2B | +9.1% |
| Q2 2025 | $2.3B | +39% |
| Q1 2025 | $1.4B | -6.7% |
| Q4 2024 | $2.1B | -1.9% |
TRV's free cash flow was $10.7B over the past year, up 6.9% from the year before. Free cash flow isn't a meaningful measure for financial services companies like TRV.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
TRV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -3M shares |
| 1 year | -7.4% | -16.9M shares |
| 3 years | -8.9% | -20.5M shares |
| 5 years | -16% | -39.5M shares |
| Available history | -20% | -51.7M shares |
TRV has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.5B |
| Q2 2026 | $1.3B |
| Q1 2026 | $1.8B |
| Q4 2025 | $1.6B |
| Q3 2025 | $619M |
| Q2 2025 | $500M |
| Q1 2025 | $250M |
| Q4 2024 | $256M |
TRV spent $6.2B buying back its own shares over the past year, about four times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
TRV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
TRV has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
TRV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.5 | Overbought |
| Stochastic | 73.3 | Neutral |
TRV's weekly RSI is 70 (overbought) and its Stochastic is 73 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
TRV PE vs Financial Services Sector
| Metric | TRV | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 19% below |
| PE % | 15 | 63 | 48 pts below |
TRV has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
TRV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $384.3 | 4.9% above |
| 20 week MA | $374.7 | 7.6% above |
| 50 week MA | $327.7 | 23% above |
| 100 week MA | $295.1 | 37% above |
| 200 week MA | $247.2 | 63% above |
TRV has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
TRV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $136.8 | $138.5 | +1.2% |
| 2021 | $138.5 | $154.7 | +12% |
| 2022 | $154.7 | $189.5 | +23% |
| 2023 | $189.5 | $190.5 | +0.5% |
| 2024 | $190.5 | $241.4 | +27% |
| 2025 | $241.4 | $292.1 | +21% |
| 2026 YTD | $292.1 | $403.2 | +38% |
TRV has the edge over BAC on returns for 2026, with the stronger performance.